I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Topalian, Suzanne L.
168
results:
Search for persons
X
Format
Online (168)
Mediatypes
Articles (Online) (68)
OpenAccess-fulltext (100)
Sorted by: Relevance
Sorted by: Year
?
1
T antigen–specific CD8+ T cells associate with PD-1 blockad..:
Hansen, Ulla Kring
;
Church, Candice D.
;
Carnaz Simões, Ana Micaela
...
Journal of Clinical Investigation. 134 (2024) 8 - p. , 2024
Link:
https://doi.org/10.1172/..
?
2
Comparing anti-tumor and anti-self immunity in a patient wi..:
Chen, Shuming
;
McMiller, Tracee L.
;
Soni, Abha
...
Journal of Translational Medicine. 22 (2024) 1 - p. , 2024
Link:
https://doi.org/10.1186/..
?
3
Circulating cancer-specific CD8 T cell frequency is associa..:
Pulliam, Thomas
;
Jani, Saumya
;
Jing, Lichen
...
Cell Reports Medicine. 5 (2024) 2 - p. 101412 , 2024
Link:
https://doi.org/10.1016/..
?
4
Nivolumab with or without ipilimumab in patients with recur..:
Oaknin, Ana
;
Moore, Kathleen
;
Meyer, Tim
...
The Lancet Oncology. 25 (2024) 5 - p. 588-602 , 2024
Link:
https://doi.org/10.1016/..
?
5
Five-Year Clinical Outcomes after Neoadjuvant Nivolumab in ..:
Rosner, Samuel
;
Reuss, Joshua E.
;
Zahurak, Marianna
...
Clinical Cancer Research. 29 (2023) 4 - p. 705-710 , 2023
Link:
https://doi.org/10.1158/..
?
6
Neoadjuvant immune checkpoint blockade: A window of opportu..:
Topalian, Suzanne L.
;
Forde, Patrick M.
;
Emens, Leisha A.
...
Cancer Cell. 41 (2023) 9 - p. 1551-1566 , 2023
Link:
https://doi.org/10.1016/..
?
7
Combinatorial biomarker for predicting outcomes to anti-PD-..:
Deutsch, Julie Stein
;
Lipson, Evan J.
;
Danilova, Ludmila
...
Cell Reports Medicine. 4 (2023) 2 - p. 100947 , 2023
Link:
https://doi.org/10.1016/..
?
8
Analysis of multispectral imaging with the AstroPath platfo..:
Berry, Sneha
;
Giraldo, Nicolas A.
;
Green, Benjamin F.
...
Science. 372 (2021) 6547 - p. , 2021
Link:
https://doi.org/10.1126/..
?
9
Three-year survival, correlates and salvage therapies in pa..:
Nghiem, Paul
;
Bhatia, Shailender
;
Lipson, Evan J
...
Journal for ImmunoTherapy of Cancer. 9 (2021) 4 - p. e002478 , 2021
Link:
https://doi.org/10.1136/..
?
10
Neoadjuvant nivolumab for patients with resectable HPV-posi..:
Ferris, Robert L
;
Spanos, William C
;
Leidner, Rom
...
Journal for ImmunoTherapy of Cancer. 9 (2021) 6 - p. e002568 , 2021
Link:
https://doi.org/10.1136/..
?
11
Neoadjuvant checkpoint blockade for cancer immunotherapy:
Topalian, Suzanne L.
;
Taube, Janis M.
;
Pardoll, Drew M.
Science. 367 (2020) 6477 - p. , 2020
Link:
https://doi.org/10.1126/..
?
12
Characterization of the tumor immune microenvironment in hu..:
Succaria, Farah
;
Kvistborg, Pia
;
Stein, Julie E.
...
Cancer Immunology, Immunotherapy. 70 (2020) 5 - p. 1227-1237 , 2020
Link:
https://doi.org/10.1007/..
?
13
Integrative Tumor and Immune Cell Multi-omic Analyses Predi..:
Anagnostou, Valsamo
;
Bruhm, Daniel C.
;
Niknafs, Noushin
...
Cell Reports Medicine. 1 (2020) 8 - p. 100139 , 2020
Link:
https://doi.org/10.1016/..
?
14
Defining tumor resistance to PD-1 pathway blockade: recomme..:
Kluger, Harriet M.
;
Tawbi, Hussein A.
;
Ascierto, Maria L.
...
Journal for ImmunoTherapy of Cancer. 8 (2020) 1 - p. e000398 , 2020
Link:
https://doi.org/10.1136/..
?
15
Neoadjuvant nivolumab plus ipilimumab in resectable non-sma..:
Reuss, Joshua E
;
Anagnostou, Valsamo
;
Cottrell, Tricia R
...
Journal for ImmunoTherapy of Cancer. 8 (2020) 2 - p. e001282 , 2020
Link:
https://doi.org/10.1136/..
1-15